Halyard Health (NYSE: HYH) and Exactech (NASDAQ:EXAC) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.
Insider & Institutional Ownership
91.0% of Halyard Health shares are owned by institutional investors. Comparatively, 64.6% of Exactech shares are owned by institutional investors. 1.3% of Halyard Health shares are owned by insiders. Comparatively, 28.3% of Exactech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
This table compares Halyard Health and Exactech’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of recent recommendations for Halyard Health and Exactech, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Halyard Health currently has a consensus price target of $41.67, suggesting a potential downside of 9.50%. Given Halyard Health’s higher probable upside, analysts plainly believe Halyard Health is more favorable than Exactech.
Risk and Volatility
Halyard Health has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Comparatively, Exactech has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500.
Valuation and Earnings
This table compares Halyard Health and Exactech’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Halyard Health||$1.60 billion||1.35||$182.00 million||$1.03||44.70|
|Exactech||$262.96 million||1.84||$43.51 million||$0.04||847.71|
Halyard Health has higher revenue and earnings than Exactech. Halyard Health is trading at a lower price-to-earnings ratio than Exactech, indicating that it is currently the more affordable of the two stocks.
Halyard Health beats Exactech on 9 of the 14 factors compared between the two stocks.
Halyard Health Company Profile
Halyard Health, Inc. is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections. The Company address healthcare needs, such as reducing the use of opioids, while helping patients move from surgery to recovery. The Medical Devices segment’s products include post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes. The S&IP segment includes product offerings, such as sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves.
Exactech Company Profile
Exactech, Inc. develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines. The Company distributes joint replacement systems, including knee, hip, spine and extremity implant systems, and biologic products and services and bone cement materials used in orthopedic surgery and dental procedures. The Exactech Knee System provides solutions for partial, primary and revision total knee arthroplasty. Its hip solutions address the continuum of hip arthroplasty. It manufactures and distributes various products and services designed for the healing and regeneration of bone and soft tissue, including products, which contain human allograft.
Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.